Diabetes during the COVID-19 pandemic: A global call to reconnect with patients and emphasize lifestyle changes and optimize glycemic and blood pressure control.
作者信息
Misra Anoop, Bloomgarden Zachary
机构信息
Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India.
Department of Medicine, Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York.
出版信息
J Diabetes. 2020 Jul;12(7):556-557. doi: 10.1111/1753-0407.13048.
Abstract
摘要
相似文献
1
Diabetes during the COVID-19 pandemic: A global call to reconnect with patients and emphasize lifestyle changes and optimize glycemic and blood pressure control.2019冠状病毒病大流行期间的糖尿病：呼吁全球重新与患者建立联系，强调生活方式改变并优化血糖和血压控制。
J Diabetes. 2020 Jul;12(7):556-557. doi: 10.1111/1753-0407.13048.
2
Issues for the management of people with diabetes and COVID-19 in ICU.ICU 中合并 COVID-19 的糖尿病患者的管理问题。
Cardiovasc Diabetol. 2020 Jul 20;19(1):114. doi: 10.1186/s12933-020-01089-2.
3
COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?新冠疫情：男性高死亡率是由性别特定剂量效应所致吗？
Immunogenetics. 2020 Jul;72(5):275-277. doi: 10.1007/s00251-020-01165-7.
4
The challenges and benefits of online teaching about diabetes during the COVID-19 pandemic.2019年冠状病毒病疫情期间糖尿病在线教学的挑战与益处。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):575-576. doi: 10.1016/j.dsx.2020.04.043. Epub 2020 May 11.
5
Clinical considerations for patients with diabetes in times of COVID-19 pandemic.2019冠状病毒病大流行期间糖尿病患者的临床考量
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):451-453. doi: 10.1016/j.dsx.2020.03.005. Epub 2020 Mar 16.
6
COVID-19 and diabetes: Covidiabetology.2019冠状病毒病与糖尿病：新冠糖尿病学
J Pak Med Assoc. 2020 Jun;70(6):954-955.
7
Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies.治疗 COVID-19 患者的 2 型糖尿病：注射治疗的潜在益处。
Cardiovasc Diabetol. 2020 Jul 22;19(1):115. doi: 10.1186/s12933-020-01090-9.
8
Relative Limited Impact of COVID-19 on Diabetes: A Personal View.新冠病毒病对糖尿病的相对有限影响：个人观点
J Diabetes Sci Technol. 2020 Jul;14(4):727-728. doi: 10.1177/1932296820930270. Epub 2020 May 29.
9
Challenges Faced by Medical Journals During the COVID-19 Pandemic.新冠疫情期间医学期刊面临的挑战
J Clin Oncol. 2020 Jul 1;38(19):2206-2207. doi: 10.1200/JCO.20.00858. Epub 2020 Apr 8.
10
COVID-19 and diabetes: What does the clinician need to know?新型冠状病毒肺炎与糖尿病：临床医生需要了解什么？
Prim Care Diabetes. 2020 Oct;14(5):558-563. doi: 10.1016/j.pcd.2020.06.010. Epub 2020 Jul 3.
引用本文的文献
1
Preserved seasonal variation in glycemic control in patients with type 2 diabetes mellitus during COVID-19: a 3-year-long retrospective cohort study in older adults in Japan.在 COVID-19 期间，2 型糖尿病患者的血糖控制保持季节性变化：日本老年人长达 3 年的回顾性队列研究。
BMC Endocr Disord. 2024 May 17;24(1):70. doi: 10.1186/s12902-024-01602-8.
2
[Impact of the alteration of the continuity of care in diabetes type 2 patients during the COVID-19 pandemic].[2型糖尿病患者在新冠疫情期间连续性照护改变的影响]
Semergen. 2022 Jul-Aug;48(5):308-315. doi: 10.1016/j.semerg.2022.02.007. Epub 2022 Mar 22.
3
Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting.专家意见：印度糖尿病环境中SGLT2i+DPP4i联合使用的最佳临床方法
Diabetes Ther. 2022 May;13(5):1097-1114. doi: 10.1007/s13300-022-01219-x. Epub 2022 Mar 25.
4
Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion.在 COVID-19 期间关注心脏代谢，在资源有限的情况下节约资源：基于临床实践的专家意见。
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):55-62. doi: 10.1016/j.dsx.2020.11.014. Epub 2020 Nov 20.
5
The burden of type 2 diabetes pre-and during the COVID-19 pandemic - a review.2型糖尿病在新冠疫情之前及期间的负担——一项综述
J Diabetes Metab Disord. 2020 Oct 19;19(2):1357-1365. doi: 10.1007/s40200-020-00656-4. eCollection 2020 Dec.
6
The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study.COVID-19 大流行对 1 型或 2 型糖尿病成人的早期影响：一项全国队列研究。
J Diabetes Complications. 2020 Dec;34(12):107748. doi: 10.1016/j.jdiacomp.2020.107748. Epub 2020 Oct 7.
7
Strict glycemic control is needed in times of COVID19 epidemic in India: A Call for action for all physicians.在印度新冠疫情期间需要严格控制血糖：呼吁所有医生采取行动。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1579-1581. doi: 10.1016/j.dsx.2020.08.003. Epub 2020 Aug 10.
8
Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India.COVID-19 及其合并症对健康和经济的影响：关注发展中国家和印度。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1625-1630. doi: 10.1016/j.dsx.2020.08.032. Epub 2020 Aug 27.
9
Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?2型糖尿病和肥胖症患者感染新冠病毒后的高凝状态：是否需要治疗剂量或更高剂量的抗凝药物进行血栓预防？
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1241-1242. doi: 10.1016/j.dsx.2020.07.015. Epub 2020 Jul 15.
10
COVID-19 in people living with diabetes: An international consensus.新型冠状病毒肺炎合并糖尿病患者的管理：国际共识。
J Diabetes Complications. 2020 Sep;34(9):107671. doi: 10.1016/j.jdiacomp.2020.107671. Epub 2020 Jul 6.
本文引用的文献
1
Ethnicity and COVID-19: an urgent public health research priority.种族与2019冠状病毒病：一项紧迫的公共卫生研究重点。
Lancet. 2020 May 2;395(10234):1421-1422. doi: 10.1016/S0140-6736(20)30922-3. Epub 2020 Apr 21.
2
Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.感染 COVID-19 的糖尿病患者有更高的 ICU 入住风险和较差的短期预后。
J Clin Virol. 2020 Jun;127:104354. doi: 10.1016/j.jcv.2020.104354. Epub 2020 Apr 9.
3
Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis.全国范围内封锁措施对控制冠状病毒感染时糖化血红蛋白恶化及糖尿病相关并发症增加的影响评估：一项使用多元回归分析的模拟模型
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):319-323. doi: 10.1016/j.dsx.2020.03.014. Epub 2020 Apr 10.
4
Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers.新型冠状病毒肺炎的合并症：高血压患者队列的结局以及肾素-血管紧张素系统阻滞剂引发的争议
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):283-287. doi: 10.1016/j.dsx.2020.03.016. Epub 2020 Apr 9.
5
Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.2019冠状病毒病大流行及全国封锁期间印度糖尿病护理的远程医疗：医生指南
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):273-276. doi: 10.1016/j.dsx.2020.04.001. Epub 2020 Apr 4.
6
Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis.新冠病毒感染患者的动脉高血压与死亡风险：系统评价与荟萃分析
J Infect. 2020 Jul;81(1):e84-e86. doi: 10.1016/j.jinf.2020.03.059. Epub 2020 Apr 11.
7
High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）需要有创机械通气患者中肥胖的高患病率。
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199. doi: 10.1002/oby.22831. Epub 2020 Jun 10.
8
Covid-19 and Health Care's Digital Revolution.新冠疫情与医疗保健的数字革命
N Engl J Med. 2020 Jun 4;382(23):e82. doi: 10.1056/NEJMp2005835. Epub 2020 Apr 2.
9
Top 10 Tips for Successfully Implementing a Diabetes Telehealth Program.成功实施糖尿病远程医疗计划的 10 大提示。
Diabetes Technol Ther. 2020 Dec;22(12):920-928. doi: 10.1089/dia.2020.0042. Epub 2020 Apr 21.
10
Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China.中国民众在 2019 年冠状病毒病（COVID-19）疫情初期的即时心理反应及相关因素。
Int J Environ Res Public Health. 2020 Mar 6;17(5):1729. doi: 10.3390/ijerph17051729.
Zotero 插件